• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Free ACCA & CIMA online courses from OpenTuition

Free ACCA & CIMA online courses from OpenTuition

Free Notes, Lectures, Tests and Forums for ACCA and CIMA exams

  • ACCA
  • CIMA
  • FIA
  • OBU
  • Books
  • Forums
  • Ask AI
  • Search
  • Register
  • Login
  • ACCA Forums
  • Ask ACCA Tutor
  • CIMA Forums
  • Ask CIMA Tutor
  • FIA
  • OBU
  • Buy/Sell Books
  • All Forums
  • Latest Topics

June 2025 ACCA Exam Results

Comments & Instant poll >>

20% off ACCA & CIMA Books

OpenTuition recommends the new interactive BPP books for June 2025 exams.
Get your discount code >>

Finance Cost & Income tax expense

Forums › Ask ACCA Tutor Forums › Ask the Tutor ACCA FR Exams › Finance Cost & Income tax expense

  • This topic has 2 replies, 2 voices, and was last updated 1 year ago by P2-D2.
Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • May 27, 2024 at 1:30 pm #706118
    sarbrina
    Participant
    • Topics: 57
    • Replies: 78
    • ☆☆

    Hi i have 2 questions in relation to this question. Please help me
    i.) Please explain to me how they calculated the finance cost in this question. I understand how to calculate the liability and equity element. Its what they have done after is what i dont understand. Please explain it to me
    ii.) Can you also please explain how they have calculated the income tax expense in this question.

    Q,) The following trial balance relates to Xtol Co at 31 March 20X4:
    $’000 $’000
    Revenue 490,000
    Cost of sales 290,600
    Distribution costs 33,500
    Administrative expenses 36,800
    Loan note interest and dividends paid (notes(iv) and (v)) 13,380
    Bank interest 900
    Right of use asset – leased property at cost 100,000
    Plant and equipment at cost (note (ii)) 155,500

    $’000 $’000
    Accumulated amortisation/depreciation at 1 April 20X3:
    Right of use asset 25,000
    Plant and equipment 43,500
    Inventories at 31 March 20X4 61,000
    Trade receivables 63,000
    Trade payables 32,200
    Bank 5,500
    Equity shares of 25 cents each (note (iii)) 56,000
    Share premium 25,000
    Retained earnings at 1 April 20X3 26,080
    5% convertible loan note (note (iv)) 50,000
    Current tax (note (vi)) 3,200
    Deferred tax (note (vi)) _______ 4,600
    757,880 757,880
    The following notes are relevant:
    (i) Revenue includes an amount of $20 million for cash sales made through Xtol Co’s retail outlets during the
    year on behalf of Francais. Xtol Co, acting as agent, is entitled to a commission of 10% of the selling price of
    these goods. By 31 March 20X4, Xtol Co had remitted to Francais $15 million (of the $20 million sales) and
    recorded this amount in cost of sales.
    (ii) Plant and equipment is depreciated at 12½% per annum on the reducing balance basis. All amortisation and
    depreciation of non-current assets is charged to cost of sales.
    (iii) On 1 August 20X3, Xtol Co made a fully subscribed rights issue of equity share capital based on two new
    shares at 60 cents each for every five shares held. The issue has been fully recorded in the trial balance
    figures.
    (iv) On 1 April 20X3, Xtol Co issued a 5% $50 million convertible loan note at par. Interest is payable annually in
    arrears on 31 March each year. The loan note is redeemable at par or convertible into equity shares at the
    option of the loan note holders on 31 March 20X6. The interest on an equivalent loan note without the
    conversion rights would be 8% per annum.
    The present values of $1 receivable at the end of each year, based on discount rates of 5% and 8%, are:
    5% 8%
    End of year 1 0.95 0.93
    2 0.91 0.86
    3 0.86 0.79
    (v) An equity dividend of 4 cents per share was paid on 30 May 20X3 and, after the rights issue, a further
    dividend of 2 cents per share was paid on 30 November 20X3.
    (vi) The balance on current tax represents the under/over provision of the tax liability for the year ended 31
    March 20X3. A provision of $28 million is required for current tax for the year ended 31 March 20X4 and at
    this date the deferred tax liability was assessed at $8.3 million.
    Required
    (a) Prepare the statement of profit or loss for Xtol Co for the year ended 31 March 20X4 (8 marks)
    (b) Prepare the statement of financial position for Xtol Co for the year ended 31 March 20X4 (12 marks)

    May 27, 2024 at 1:43 pm #706121
    sarbrina
    Participant
    • Topics: 57
    • Replies: 78
    • ☆☆

    And also please explain why the deferred tax is added and not subtracted from the income tax expense.

    June 1, 2024 at 10:52 am #706373
    P2-D2
    Keymaster
    • Topics: 4
    • Replies: 7172
    • ☆☆☆☆☆

    The deferred tax movement would be added and not subtracted from the income tax expense as the movement will be a debit to the income tax expense account, being the other side of the entry from the credit to the deferred tax balance on the SFP.

    Thanks

  • Author
    Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.
Log In

Primary Sidebar

Donate
If you have benefited from our materials, please donate

ACCA News:

ACCA My Exam Performance for non-variant

Applied Skills exams is available NOW

ACCA Options:  “Read the Mind of the Marker” articles

Subscribe to ACCA’s Student Accountant Direct

ACCA CBE 2025 Exams

How was your exam, and what was the exam result?

BT CBE exam was.. | MA CBE exam was..
FA CBE exam was.. | LW CBE exam was..

Donate

If you have benefited from OpenTuition please donate.

PQ Magazine

Latest Comments

  • roksy on Illegalities – ACCA Corporate and Business Law (LW) (ENG)
  • Fola94 on Presentation of financial statements – introduction – ACCA Financial Reporting (FR)
  • John Moffat on Financial management objectives – ACCA Financial Management (FM)
  • sallauddinsk on Financial management objectives – ACCA Financial Management (FM)
  • kmottea on IASB Conceptual Framework – Introduction – ACCA Financial Reporting (FR)

Copyright © 2025 · Support · Contact · Advertising · OpenLicense · About · Sitemap · Comments · Log in